Showing results (211-220 of 490) with videos related to

Sort By:
Pageof 49
Journal of Endocrinological Investigation|March 30, 2007
Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entityA Agha, R Carpenter, S Bhattacharya, et al.
Acta Paediatrica Scandinavica. Supplement|January 1, 1987
Growth hormone releasing hormone in the assessment and long-term treatment of growth hormone deficiencyR J Ross, A Grossman, M A Preece, et al.
The Journal of Endocrinology|October 1, 1991
Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjectsE Ur, M Faria, S Tsagarakis, et al.
Clinical Endocrinology|October 1, 1996
Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapyP J Jenkins, A Jain, S L Jones, et al.
Clinical Endocrinology|March 1, 1982
The role of opiate peptides in the control of prolactin in the puerperium, and TSH in primary hypothyroidismA Grossman, S West, J Williams, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1975
Lipid mobilizing hormones of the hypothalamus and pituitaryA J Kastin, T W Redding, R Hall, et al.
Clinical Science (London, England : 1979)|February 1, 1987
Dissociation between circulating concentrations of immunoreactive growth hormone releasing factor and growth hormone in normal human subjectsA M Sopwith, E S Penny, N Lytras, et al.
Clinical Endocrinology|February 1, 1991
Thyroxine replacement in post-radioiodine hypothyroidismC P Bearcroft, G C Toms, S J Williams, et al.
QJM : Monthly Journal of the Association of Physicians|September 1, 1996
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)D Trump, B Farren, C Wooding, et al.
Nuclear Medicine Communications|December 1, 1984
Imaging of phaeochromocytoma and adrenal medulla with 123I-meta-iodobenzyl guanidineT Horne, L A Hawkins, K E Britton, et al.
Pageof 49